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Abstract A new human zinc finger DNA-binding protein was
identified by using a yeast one-hybrid selection system. Two
versions of the cDNA, encoding the same protein, were detected
that differ for a 584 bp extension at the 5P region. Sequence
analysis showed that the longer clone is a full length version
containing part of the 5P untranslated region. The smaller version
was fused in frame with the yeast GAL4 activation domain
whereas the 5P region of the longer clone displayed a stop codon
interrupting the fusion with the GAL4 domain. Nevertheless, this
clone activated the yeast HIS3 reporter gene with the same
efficiency as the smaller version. Sequence comparison of the
derived protein with the database showed that it belongs to a
family of zinc finger DNA-binding proteins which regulate the
expression of genes involved in cell proliferation. Expression of
the protein in an in vitro system, DNA-binding studies and
genetic experiments identify this factor as a new zinc finger
DNA-binding protein which binds GC-rich sequences and
contains a domain probably functioning as a transcriptional
activator. The new human protein identified in this study was
therefore named GC-box-binding zinc finger protein).
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1. Introduction
The yeast one-hybrid system is an in vivo assay aimed to
identify cDNA sequences for proteins which can bind a target
DNA and activate expression of a reporter gene in yeast cells
[1]. This method is of peculiar advantage especially when
DNA-binding factors are present in a minute amount in the
cell, making standard puri¢cation techniques cumbersome
and time consuming. We wanted to apply this approach to
search for DNA-binding proteins able to interact with the 3P
end of the D-loop of human mitochondrial DNA (mtDNA).
This region contains conserved sequences, known as termina-
tion-associated sequences (TAS), which might constitute cis
elements for termination of mtDNA synthesis [2^7]. In vivo
and in vitro experiments previously suggested the presence of
proteins that bind such sequences and might be involved in
the regulation of the mtDNA copy number [8,9].
In this study, we report the cloning of a human cDNA
encoding a new member of the Kru«ppel zinc ¢nger protein
family [10], by using a non-traditional yeast one-hybrid
screening approach. Because the protein is able to bind GC-
rich sequences, we have named it GC-box-binding zinc ¢nger
protein (GZP1). The observation that the protein is able to
activate the expression of the HIS3 reporter gene even in the
absence of the GAL4 domain points toward a transcription
activation function of GZP1. Furthermore, the ¢nding that
GZP1 is most likely a nuclear factor interacting with a mito-
chondrial target sequence in the one-hybrid screening is of
importance for further experiments with this system.
2. Materials and methods
2.1. Yeast one-hybrid screening and cDNA characterization
To construct the target DNA for selecting DNA-binding domains
encoded in the human libraries, a 369 bp fragment (nucleotides (nt)
16 049^16 417) was PCR-ampli¢ed from human ¢broblast total DNA
with primers H-TAS-For (nt 16 049^16 070) and H-TAS-Rev (nt
16 417^16 396). mtDNA positions are according to Anderson et al.
[11]. The product was subcloned into the pMOSBlue vector (Amer-
sham), recovered as an EcoRI-XbaI fragment of 420 bp and inserted
into reporter plasmid pHISi-1 (Clontech) in front of the HIS3 gene,
generating the TAS-HIS3 reporter cassette. The recombinant plasmid
was linearized with XhoI and introduced into the genome of the yeast
strain YM4271. For all transformation procedures, lithium acetate-
polyethylene glycol treatment was followed [12]. The basal activity of
the HIS3 gene was su⁄cient to identify colonies that have integrated
the construct into the genome. They were further checked for growth
on medium lacking histidine (His3 medium) in the presence of 10 mM
3-aminotriazol (3-AT). Cells whose growth was inhibited under these
conditions were chosen as the host for the library screening. Two
Matchmaker cDNA libraries (Clontech) from human testis and fetal
liver were used with their cDNA sequences cloned into the vector
pACT2 that encodes the GAL4 activation domain.
Library plasmids were prepared by alkaline lysis [13] and trans-
formed into the aploid yeast strain Y187 (MAT K) generating about
2U106 independent transformed yeast colonies for both libraries. Ali-
quots of transformed cells were mated for 16 h at 28‡C with the
aploid yeast strain YM4271 (MAT a) containing the TAS-HIS3 re-
porter cassette. The resulting diploids were plated on selective medium
lacking histidine and leucine but containing 10 mM 3-AT and incu-
bated at 28‡C. After 3^5 days, positive colonies were observed from
screenings with both libraries. They were tested on minimal plates
with increasing concentrations of 3-AT ranging from 5 to 60 mM.
Plasmids from putative positive clones were isolated by standard
techniques [13] and transferred into RR1 and DH5K Escherichia coli
strains. For back transformation, the putative positive plasmids were
individually re-introduced into yeast cells containing the TAS-HIS3
reporter cassette and tested for growth on selective medium. The
0014-5793 / 99 / $20.00 ß 1999 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 9 9 ) 0 0 7 5 4 - 1
*Corresponding author. Fax: (39) (080) 544 3317.
E-mail: p.cantatore@biologia.uniba.it
1 These authors contributed equally to this work.
FEBS 22208 18-6-99
FEBS 22208 FEBS Letters 453 (1999) 369^374
nucleotide sequence was determined on both strands by the biochem-
ical method of Sanger and by automated sequencing and used to
query the GenBank database. Sequence comparisons were made by
using Clustal software [14].
2.2. In vitro translation of GZP1 cDNA
A plasmid construct bearing the short form of GZP1 suitable for in
vitro translation was obtained as follows. The corresponding cDNA
insert in the pACT2 plasmid was PCR-ampli¢ed (Expand High Fidel-
ity PCR System Boehringer) with a forward primer containing the
SalI site and the sequence of the initiation codon in the Kozak con-
sensus [15] and with a reverse primer encompassing the XhoI site of
the pACT2 polylinker. The product was then cloned into the same
restriction sites of pCITE plasmid (Novagen). The correct nucleotide
sequence of the construct was veri¢ed. The protein was synthesized
using 1 Wg of recombinant plasmid and the TNT Coupled Reticulo-
cyte kit (Promega) according to the manufacturer’s protocol, in the
presence or in the absence of [35S]methionine.
2.3. Electrophoretic mobility shift assay (EMSA)
EMSA was performed in a 20 Wl volume containing 20 mM Tris-
HCl, pH 7.9, 10 mM glycerol, 6 mM MgCl2, 1 mM EDTA, 100 WM
ZnSO4, 0.4 ng labelled probe and 6 Wl of in vitro translated protein.
The gERE probe [16] was prepared by annealing the complementary
oligonucleotides 5P-ATGGGGCGGGGTGGGGGG-3P and 5P-
ATCCCCCCACCCCGCCCC-3P. Probes TAS1 and TAS2 were dou-
ble-stranded oligonucleotides designed on the human mtDNA se-
quence [11], from nt 16 143 to nt 16 196 and from nt 16 301 to nt
16 360, respectively. Probes were then end-labelled with [K-32P]dATP,
using Klenow enzyme. For competition experiments, varying amounts
of di¡erent double-stranded oligonucleotides were included in the re-
action. After incubation at room temperature for 30 min, samples
were analyzed on a non-denaturing 6% polyacrylamide gel in 0.5U
Tris-borate-EDTA bu¡er.
2.4. Transcription activation activity test
A plasmid construct bearing the short form of GZP1 for an acti-
vation test was obtained as follows. The insert was PCR-ampli¢ed
(Expand High Fidelity PCR System Boehringer) from the correspond-
ing recombinant pACT2 plasmid, using a forward primer containing
the XbaI site and the sequence of the initiation codon in the Kozak
consensus [15] and a reverse primer encompassing the BglII site of the
pACT2 polylinker. The XbaI-BglII fragment was inserted into XbaI-
BamHI sites of the YEp351-ADH vector [17] and the correct nucleo-
tide sequence of the construct was veri¢ed. Plasmids were used to
transform yeast cells containing the TAS-HIS3 reporter cassette.
Transformants were tested for their growth ability on His3 plates
with increasing amounts of 3-AT as speci¢ed in Table 1.
3. Results
3.1. Isolation of human DNA-binding factors by using a yeast
one-hybrid selection system
In order to identify and clone the cDNA for DNA-binding
proteins interacting with the TAS region of human mtDNA,
we used a modi¢cation of the classic one-hybrid screening [1],
which makes use of the mating procedure for yeast transfor-
mation. This protocol, originally developed for the two-hybrid
system [18], employs two yeast strains of a di¡erent mating
type (YM4271 (MAT a) and Y187 (MAT K)) which are trans-
formed with the reporter plasmid and with the entire cDNA
expression library, respectively. After mating, the screening of
an entire cDNA library can be performed much faster with
respect to the traditional procedure as it is limited only by the
number of plates that can be handled. Moreover, yeast cells
can directly express the fusion protein without delay which
avoids losses of positive clones as sometimes observed in the
traditional transformation procedure.
To construct the DNA target site, a 369 bp fragment con-
taining the TAS sequences was inserted into the reporter vec-
tor pHISi-1 in front of the yeast HIS3 gene and introduced
into the genome of the YM4271 yeast strain. Two human
cDNA plasmid libraries from fetal liver and testis tissue,
cloned into the pACT2 vector, were transformed into the
Y182 yeast strain. A total of seven independent colonies
showing good growth on selective media were selected. They
were tested on minimal plates with di¡erent amounts of 3-AT
and good growth was observed up to a concentration of 60
mM 3-AT. Separate back transformation of the isolated re-
combinant pACT2 plasmids into the yeast reporter strain al-
ways resulted in the same good growth even at high levels of
3-AT. Restriction analysis of cDNA inserts from the seven
clones allowed them to be grouped into two classes of ¢ve
and two clones that represent two versions of the same DNA
insert (Fig. 1). Five clones contained a cDNA insert of 3097
bp whereas in the other two, the insert was 584 bp shorter.
Sequence analysis revealed long open reading frames for both
types of cDNA inserts. The 3P region always included the
polyA tail and was found to be identical whereas the 5P region
exhibited di¡erences. The longer insert represents a full length
cDNA clone even with part of the 5P untranslated region
(5P UTR) (EMBL accession number AJ132592). Interestingly,
a stop codon was found in the 5P UTR that interrupts the
continuous reading frame from the upstream yeast GAL4
domain in the fusion protein. On the contrary, the shorter
cDNA insert (EMBL accession number AJ132591) was fused
in frame with the GAL4 domain.
The longer reading frame predicts a 895 amino acid long
polypeptide whose main features are summarized in Fig. 2.
The protein contains four C2H2 zinc ¢ngers (from residue 263
to 368) that are separated by the consensus motif
STGREKRPFY. This identi¢es the protein as a possible mem-
ber of the Kru«ppel zinc ¢nger family [10]. Other features of
the protein are the presence of tracts of poly-glycine (residues
4^37), poly-proline (residues 86^96) and poly-histidine (resi-
dues 141^148) and of a basic domain (residues 219^236) con-
Table 1
Growth test of the YM4271 yeast strain bearing the TAS-HIS3 cassette on minimal medium with di¡erent concentrations of 3-AT
TAS-HIS3 reporter yeast strain 3-AT concentration
0 mM 5 mM 15 mM 30 mM 45 mM 60 mM
No plasmid + 3 3 3 3 3
pACT2-Short GZP1 + + + + + +
pACT2-Long GZP1 + + + + + +
YEp351-ADH-Short GZP1 + + + + + +
The yeast strain carries the HIS3 cassette as a genomic copy. This strain was transformed with di¡erent constructs of GZP1 cDNA cloned into
the pACT2 vector with the yeast GAL4 activation domain or the yeast YEp351 vector that lacks the GAL4 activation domain but has the
yeast ADH promoter. When cloned into pACT2, Short GZP1 cDNA was in frame with the yeast GAL4 activation domain, while Long GZP1
was not, as it contains a stop codon in the 5P UTR. Growth of the colonies was evaluated after 2 days: +, good growth; 3, no growth.
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taining a bipartite nuclear localization signal [19]. Another
nuclear localization signal is placed between residues 403^
409. A BLASTP search of the protein database revealed a
consistent similarity (28% identity plus 30% similarity) with
the human protein ZBP-89 [20]. ZBP-89 is a zinc ¢nger DNA-
binding protein that recognizes GC-rich sequences and is in-
volved in the control of the expression of several promoters
and inhibits cell proliferation [21^25]. Therefore, it is likely
that our protein was selected for its ability to recognize and
bind the GC-rich tracts contained in the mtDNA target frag-
ment [11]. On these bases, the protein was named GZP1. The
alignment of the amino acid sequences of GZP1 and ZBP-89
is reported in Fig. 3. GZP1 is 134 amino acid longer than
ZBP-89, this di¡erence being mostly due to the amino-termi-
nal extension of GZP1. This implies that ZBP-89 lacks the
poly-histidine, poly-proline and poly-glycine tracts present in
GZP1. On the other hand, GZP1 does not contain the acidic
domain observed in ZBP-89 between residues 56 and 98. The
four zinc ¢ngers, the consensus motif and the nuclear local-
ization signals are found in corresponding positions in both
GZP1 and ZBP-89.
3.2. Structure-function studies of recombinant GZP1
In order to assess the binding capacity of GZP1, the shorter
version of its cDNA was subcloned into the expression vector
pCITE and subjected to in vitro transcription-translation in a
rabbit reticulocyte lysate. A single product of about 90 kDa
was observed after SDS-gel electrophoresis (Fig. 4A). The
synthesized protein was assayed in gel-shift experiments using
an oligonucleotide as a probe (gERE) which is known to be
bound by zinc ¢nger proteins that, like ZBP-89, recognize
GC-rich sequences [21]. Fig. 4B shows that the protein is
able to bind the probe, thereby producing a retarded band.
The binding is sequence-speci¢c as the retarded band disap-
pears when increasing amounts of the same cold oligonucleo-
tide are added to the reaction mixture. On the contrary, large
amounts of an heterologous oligonucleotide did not compete
with the gERE probe in binding to the protein (data not
shown). The synthesized protein also formed a complex
(Fig. 4C) with the oligonucleotide TAS1 which is comprised
in the target used for the one-hybrid screen and contains a
GC-box. The complex was speci¢c as con¢rmed by a compe-
tition assay. No complex was formed when probe TAS2,
which does not contain GC-rich sequences, was used (data
not shown). This con¢rms that our protein was selected for
its ability to recognize and bind the GC-rich tracts contained
in the mtDNA target fragment [11].
The ¢nding that the complete GZP1 gene is not fused with
the yeast GAL4 activation domain but still activates the HIS3
gene e⁄ciently in the yeast one-hybrid screening prompted us
to address the question whether the short form is also able to
activate the HIS3 gene on its own when separated from the
GAL4 activation domain. For this purpose, the short frag-
ment was cloned into the yeast expression vector YEp351
under the control of the yeast ADH promoter but without
the GAL4 activation domain. After introduction of this con-
struct into the yeast reporter strain bearing the TAS-HIS3
cassette, good growth was observed in 3-AT-containing
His3 medium (Table 1). The growth under selective condi-
tions was comparable to that observed for plasmids pACT2-
Long GZP1 and pACT2-Short GZP1 when transformed into
the same reporter strain. These results indicate that the GZP1
gene product does contain a transcription activation domain
of its own. Additionally, the presence of a nuclear localization
Fig. 2. Domain structure of the GZP1 protein. The protein is 895
amino acids long. Characteristic domains and their amino acid posi-
tions are shown. G: glycine-rich region; H: poly-histidine region;
P: proline-rich region; ZF: four zinc ¢nger domains of the C2H2
type; NLS: nuclear localization sequences.
Fig. 1. Restriction map of GZP1 Short and GZP1 Long cDNA clones identi¢ed by the one-hybrid screening. The human cDNA inserts, cloned
as EcoRI-XhoI fragments, are represented by blocks. A thin line indicates £anking sequences of the pACT2 vector. The gray box in the long
insert labels sequences that are not found in the shorter fragment. The di¡erence between the short and long clone is due to 584 bp starting
from the identical priming site used for cDNA construction. Arrows mark the length and direction of the open reading frames. The reading
frame of GZP1 Short cDNA is in frame with the upstream GAL4 activation domain (indicated by a broken line), whereas the GZP1 Long in-
sert has a reading frame that starts from its own ¢rst ATG. Abbreviations for restrictions are the following: B, BamHI; Bg, BglII; E, EcoRI;
P, PstI; X, XhoI).
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domain is con¢rmed, since YEp-351 vector does not provide
the expressed protein with a nuclear localization signal [17], as
does the GAL4 fusion plasmid pACT2.
4. Discussion
In this paper, we report the isolation of a human cDNA for
a new zinc ¢nger DNA-binding protein, GZP1, that belongs
to a protein family interacting with GC-rich sequence ele-
ments [10]. By using a yeast one-hybrid selection system, we
found two classes of clones as the only positive signals di¡er-
ing only in their 5P regions. The short version of GZP1 does
not contain the initiating methionine and is in frame with the
yeast GAL4 activation domain. On the contrary, the long
version, which represents the complete protein, is not fused
in frame with the GAL4 domain, as a stop codon between the
two sequences, probably belonging to the 5P UTR of GZP1,
interrupts the frame. However, both versions of GZP1 medi-
ate the same good growth of the yeast strain even at high
concentrations of 3-AT. The conclusion from these ¢ndings
is that in yeast, the long version is translated from the ¢rst
possible ATG as the start codon. This would imply that the
human protein contains a nuclear import sequence (or sequen-
ces) of its own and also a transcription activation domain that
is functional in yeast. The GZP1 sequence indeed displays two
canonical nuclear targeting sequences, one in the main basic
domain between residues 219 and 236 and the other between
residues 403 and 409. This ¢nding is further veri¢ed by ex-
pressing the short version of the GZP1 gene in the yeast YEp
vector that lacks the GAL4 activation domain. The construct
is able to activate the TAS-HIS3 cassette with the same e⁄-
ciency as pACT2 plasmids bearing the short and complete
version of GZP1. As the shorter version of the GZP1 gene
does not contain the tracts of poly-glycine, poly-proline and
poly-histidine at the amino-terminus, those domains may not
be essential for the transcription activation activity.
GZP1 shows a substantial sequence homology to an ubiq-
uitous zinc ¢nger DNA-binding protein, ZBP-89, that con-
trols several promoter systems such as that of the rat gastrin
gene [21], human ht L T-cell receptor [22], mouse BFCOL1,
Fig. 3. Sequence alignment between GZP1 and ZBP-89. Asterisks indicate identical nucleotides, colons and dots indicate very similar and simi-
lar residues, respectively, according to Thompson et al [14]. Zinc ¢nger domains are boxed. Acidic (solid line) and basic (broken line) motifs
are shown. The arrow marks the start point of GZP1 Short.
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type 1 collagen gene [23], human L enolase gene [24] and
ornitine decarboxylase gene [25]. The homology concerns pri-
marily the zinc ¢ngers and a few other regions of the two
proteins. However, there are several domains that di¡er be-
tween the two proteins and that could suggest diverse func-
tions in the cell. In particular ZBP-89 lacks the poly-glycine,
poly-histidine and poly-proline tracts present at the N-termi-
nus of GZP1. Conversely, GZP1 does not contain the long
acidic domain present in ZBP-89 which might be responsible
for protein-protein interactions [26]. An indication that GZP1
may also be an ubiquitous protein is given by our ¢nding that
the same cDNA clones were isolated from libraries from very
di¡erent tissues like liver and testis. While ZBP-89 appears to
act as a negative regulator of gene expression competing with
the Sp1 factor for binding the 5P half of gERE [21], it has been
reported that a minimum of three proteins can recognize the
GC-rich element [16] and at least one of these might exert a
positive control in transcription [24]. Our data suggest that
the newly identi¢ed GZP1 factor could be the one playing a
positive function in transcription activation. The identi¢cation
of GZP1 will allow to perform studies to address the problem
of its function in human cells and the possible interactions
with other proteins in regulating the expression of genes under
the control of GC-rich sequence elements.
In spite of extensive library screenings with large numbers
of transformed yeast cells, no additional positive clones have
been identi¢ed. In particular, we did not ¢nd any positive
clone encoding mtDNA-binding protein(s) able to speci¢cally
interact with the TAS region of human mtDNA. This means
that either the respective cDNAs are not contained in the
library or the speci¢c proteins, though present, are not de-
tected by the one-hybrid test, probably because, in order to
bind DNA, they may require post-translational modi¢cations
that do not occur in yeast. An alternative explanation is that
mtDNA-binding proteins, as all mitochondrial proteins trans-
lated in the cytoplasm and addressed to the mitochondrion,
are synthesized as precursors containing a N-terminal import
sequence of variable length [27]. The presence of the import
domain has been shown to prevent proteins from binding the
target DNA sequences [28^30], however, their DNA-binding
capacity is restored upon removal of the import sequence.
Since in our screening, we used full length cDNA libraries,
it is very likely that mitochondrial proteins were expressed as
precursors, being therefore unable to bind their target sequen-
ces. It follows that the application of the one-hybrid system
for the search of mitochondrial proteins could present some
limits. It is therefore advisable in those cases to use cDNA
libraries with short 5P deletions, which should allow mtDNA-
binding proteins to acquire the proper folding for best con-
tacting the DNA target.
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Fig. 4. DNA-binding properties of GZP1. (A) SDS-polyacrylamide
gel analysis. The shorter version of GZP1 was expressed in vitro in
the presence of [35S]methionine, separated on a SDS-polyacrylamide
gel and subjected to autoradiography. The positions of molecular
mass markers (in kDa) are shown to the left. (B) and (C) EMSA.
Aliquots of 6 Wl from in vitro transcription-translation reaction mix-
tures were incubated with the K-32P-labelled double-stranded gERE
(B) or TAS1 (C) oligonucleotide. Where indicated, a 100-fold and
500-fold molar excess of unlabelled oligonucleotide competitor was
added.
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